Challenges and Evolving Strategies in the Treatment of In-Stent Restenosis With Drug-Coated Balloons

Affiliations

¹ Department of Cardiology, Maasstad Hospital, the Netherlands (V.P.).
² Department of Cardiology, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid, IIS-IP, CIBER-CV, Spain (F.A.).

Editorial

Valeria Paradies et al. Circ Cardiovasc Interv. 2025 May.

. 2025 May;18(5):e015359.

doi: 10.1161/CIRCINTERVENTIONS.125.015359. Epub 2025 Apr 24.

¹ Department of Cardiology, Maasstad Hospital, the Netherlands (V.P.).
² Department of Cardiology, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid, IIS-IP, CIBER-CV, Spain (F.A.).

No abstract available

Keywords: Editorials; coronary restenosis; myocardial infarction; percutaneous coronary intervention; stents, drug-coated.

Conflict of interest statement

None.

Comparing the Efficacy of Sirolimus and Paclitaxel-Eluting Balloon Catheters in the Treatment of Coronary In-Stent Restenosis: A Prospective Randomized Study (TIS 2 Study).
Pleva L, Kukla P, Kovarnik T, Zapletalova J. Pleva L, et al. Circ Cardiovasc Interv. 2025 May;18(5):e014677. doi: 10.1161/CIRCINTERVENTIONS.124.014677. Epub 2025 Apr 2. Circ Cardiovasc Interv. 2025. PMID: 40171676 Clinical Trial.